Image Credit: DukiPH / Shutterstock.com Introduction Orforglipron is an orally bioavailable next-generation glucagon-like peptide 1 (GLP-1) receptor agonist (GLP-1RA) that has emerged as a potential alternative to injectable agents like semaglutide based on early Phase 1, 2, and 3 clinical trials demonstrating glucose-lowering and weight-loss efficacy without the need for injection-based delivery
Look for: Doctors who understand weight management Endocrinologists for diabetes care Primary care doctors who stay up to date Teams that offer comprehensive care At Yorktown Health, we provide personalized care for GLP-1 treatment and weight management
It also provides healthy fats that keep skin moisturized and supple
The selective antibiotic treatment allowed us to profile the microbiome composition and to evaluate the association between the microbiome and GLP-1
Zhao, Y., Hasjim, J., Li, L., Jane, J
J Extracell Vesicles 7(1):1440131 Uddin MJ, Dawan J, Jeon G, Yu T, He X, Ahn J (2020) The role of bacterial membrane vesicles in the dissemination of antibiotic resistance and as promising carriers for therapeutic agent delivery
